The effects of dehydroepiandrosterone on sexual function: a systematic review

Abstract Objective: Faced with the growing interest about the action of dehydroepiandrosterone (DHEA) and its benefits, as well as the negative impacts that sexual dysfunctions have on people’s quality of life, this systematic review was undertaken with the objective of evaluating the effect of DHEA use on aspects of sexual function. Method: An electronic search was conducted in the databases of PubMed, ISI Web of Science and Virtual Health Library (VHL) combining the terms 'DHEA treatment' and 'DHEA use' with terms such as 'sexual dysfunction', 'sexual frequency' and 'libido'. No limits on time and language were imposed. Clinical studies were considered eligible where individuals for any reason made use of DHEA and if they had any aspect of sexual function assessed. Preclinical studies and systematic reviews were considered ineligible. Results: The search identified 183 references and 38 were considered eligible. DHEA improved aspects such as sexual interest, lubrication, pain, arousal, orgasm and sexual frequency. Its effect was better in populations with sexual dysfunction, especially in perimenopausal and postmenopausal women. Conclusion: Considering the studies currently published, DHEA is effective in improving several aspects of sexual function, but this effect did not reach all the populations studied.

[1]  M. Carta,et al.  Dehydroepiandrosterone, Its Sulfate and Cognitive Functions , 2016, Clinical practice and epidemiology in mental health : CP & EMH.

[2]  L. Derogatis,et al.  Effect of intravaginal dehydroepiandrosterone (DHEA) on the female sexual function in postmenopausal women: ERC-230 open-label study , 2016, Hormone molecular biology and clinical investigation.

[3]  F. Labrie,et al.  Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause , 2016, Menopause.

[4]  L. Derogatis,et al.  Effect of Intravaginal Prasterone on Sexual Dysfunction in Postmenopausal Women with Vulvovaginal Atrophy. , 2015, The journal of sexual medicine.

[5]  F. Labrie,et al.  Influence of treatment of vulvovaginal atrophy with intravaginal prasterone on the male partner , 2015, Climacteric : the journal of the International Menopause Society.

[6]  C. Labrie,et al.  Treatment of pain at sexual activity (dyspareunia) with intravaginal dehydroepiandrosterone (prasterone) , 2015, Menopause.

[7]  L. Mota,et al.  How the rheumatologist can guide the patient with rheumatoid arthritis on sexual function. , 2015, Revista brasileira de reumatologia.

[8]  C. Labrie,et al.  Prasterone has parallel beneficial effects on the main symptoms of vulvovaginal atrophy: 52-week open-label study. , 2015, Maturitas.

[9]  J. Foidart,et al.  Restoring testosterone levels by adding dehydroepiandrosterone to a drospirenone containing combined oral contraceptive: II. Clinical effects. , 2015, Contraception.

[10]  J. Foidart,et al.  Restoring testosterone levels by adding dehydroepiandrosterone to a drospirenone containing combined oral contraceptive: I. Endocrine effects. , 2015, Contraception.

[11]  A. Nardi,et al.  The effects of dehydroepiandrosterone (DHEA) in the treatment of depression and depressive symptoms in other psychiatric and medical illnesses: a systematic review. , 2014, Current drug targets.

[12]  C. Labrie,et al.  Lack of influence of dyspareunia on the beneficial effect of intravaginal prasterone (dehydroepiandrosterone, DHEA) on sexual dysfunction in postmenopausal women. , 2014, The journal of sexual medicine.

[13]  S. Schreiber,et al.  The use of dehydroepiandrosterone in the treatment of hypoactive sexual desire disorder: A report of gender differences , 2013, European Neuropsychopharmacology.

[14]  S. Ish-shalom,et al.  Dehydroepiandrosterone treatment effects on weight, bone density, bone metabolism and mood in women suffering from anorexia nervosa—a pilot study , 2012, Psychiatry Research.

[15]  J. Rabkin,et al.  DHEA and cognition in HIV-positive patients with non-major depression. , 2012, Psychosomatics.

[16]  A. Genazzani,et al.  Effect of 1-year, low-dose DHEA therapy on climacteric symptoms and female sexuality , 2011, Climacteric : the journal of the International Menopause Society.

[17]  C. Labrie,et al.  Intravaginal dehydroepiandrosterone (prasterone), a highly efficient treatment of dyspareunia , 2011, Climacteric : the journal of the International Menopause Society.

[18]  G. Yadid,et al.  The role of dehydroepiandrosterone (DHEA) in drug-seeking behavior , 2010, Neuroscience & Biobehavioral Reviews.

[19]  A. Morales,et al.  Androgens and sexual function: a placebo-controlled, randomized, double-blind study of testosterone vs. dehydroepiandrosterone in men with sexual dysfunction and androgen deficiency , 2009, The aging male : the official journal of the International Society for the Study of the Aging Male.

[20]  R. Geenen,et al.  Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus: a randomised controlled trial , 2009, Annals of the rheumatic diseases.

[21]  C. Labrie,et al.  Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration , 2009, Menopause.

[22]  C. Labrie,et al.  Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women , 2009, Menopause.

[23]  R. Wolfe,et al.  A randomized trial of oral DHEA treatment for sexual function, well-being, and menopausal symptoms in postmenopausal women with low libido. , 2009, The journal of sexual medicine.

[24]  O. Wolkowitz,et al.  Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS) , 2009, Frontiers in Neuroendocrinology.

[25]  D. V. von Mühlen,et al.  Effects of Dehydroepiandrosterone Supplementation on Cognitive Function and Quality of Life: The DHEA and Well‐Ness (DAWN) Trial , 2008, Journal of the American Geriatrics Society.

[26]  L. Camano,et al.  Validação do índice da função sexual feminina em grávidas brasileiras , 2007 .

[27]  R. Geenen,et al.  Effect of dehydroepiandrosterone administration on fatigue, well-being, and functioning in women with primary Sjögren syndrome: a randomised controlled trial , 2007, Annals of the rheumatic diseases.

[28]  J. Monson,et al.  Dehydroepiandrosterone improves psychological well-being in male and female hypopituitary patients on maintenance growth hormone replacement. , 2006, The Journal of clinical endocrinology and metabolism.

[29]  S. Van Uum,et al.  Dehydroepiandrosterone administration in humans: evidence based? , 2005, The Netherlands journal of medicine.

[30]  J. Legros.  PSYCHONEUROENDOCRINOLOGY. The Scientific Basis of Clinical Practice, O.M. Wolkowitz, A.J. Rothschild (Eds.). American Psychiatric Publishing Inc., Washington DC, USA, London, UK (2003), pages 588, ISBN: 0-88048-857-3 , 2005 .

[31]  A. So,et al.  A randomized controlled trial of dehydroepiandrosterone in postmenopausal women with fibromyalgia. , 2005, The Journal of rheumatology.

[32]  J. Romijn,et al.  Effects of dehydroepiandrostenedione, superimposed on growth hormone substitution, on quality of life and insulin-like growth factor I in patients with secondary adrenal insufficiency: a randomized, placebo-controlled, cross-over trial. , 2005, The Journal of clinical endocrinology and metabolism.

[33]  A. Larsson,et al.  Effects of dehydroepiandrosterone supplement on health-related quality of life in glucocorticoid treated female patients with systemic lupus erythematosus , 2005, Autoimmunity.

[34]  P. Beck‐Peccoz,et al.  Effects of dehydroepiandrosterone (DHEA) supplementation on hormonal, metabolic and behavioral status in patients with hypoadrenalism , 2004, Journal of endocrinological investigation.

[35]  E. Moreira,et al.  Prevalence of sexual dysfunctions and correlated conditions in a sample of Brazilian women—results of the Brazilian study on sexual behavior (BSSB) , 2004, International Journal of Impotence Research.

[36]  M. Huell,et al.  Progesterone increase under DHEA-substitution in males. , 2003, Maturitas.

[37]  E. Husebye,et al.  Replacement of dehydroepiandrosterone in adrenal failure: no benefit for subjective health status and sexuality in a 9-month, randomized, parallel group clinical trial. , 2003, The Journal of clinical endocrinology and metabolism.

[38]  B. Bengtsson,et al.  Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial. , 2002, The Journal of clinical endocrinology and metabolism.

[39]  J. Heiman,et al.  Acute dehydroepiandrosterone (DHEA) effects on sexual arousal in postmenopausal women. , 2002, Journal of women's health & gender-based medicine.

[40]  I. Goldstein,et al.  Androgen Replacement Therapy with Dehydroepiandrosterone for Androgen Insufficiency and Female Sexual Dysfunction: Androgen and Questionnaire Results , 2002, Journal of sex & marital therapy.

[41]  J. Heiman,et al.  Acute Dehydroepiandrosterone Effects on Sexual Arousal in Premenopausal Women , 2002, Journal of sex & marital therapy.

[42]  A. Guay.  Decreased Testosterone in Regularly Menstruating Women with Decreased Libido: A Clinical Observation , 2001, Journal of sex & marital therapy.

[43]  M. Fassnacht,et al.  Dehydroepiandrosterone supplementation in healthy men with an age-related decline of dehydroepiandrosterone secretion. , 2001, The Journal of clinical endocrinology and metabolism.

[44]  E. Moreira,et al.  Prevalence and correlates of erectile dysfunction: results of the Brazilian study of sexual behavior. , 2001, Urology.

[45]  F. Huppert,et al.  Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. , 2000, The Journal of clinical endocrinology and metabolism.

[46]  E. Baulieu,et al.  Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[47]  K. Barnhart,et al.  The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life. , 2000, The Journal of clinical endocrinology and metabolism.

[48]  J. Rabkin,et al.  DHEA treatment for HIV+ patients: effects on mood, androgenic and anabolic parameters , 2000, Psychoneuroendocrinology.

[49]  B. Allolio,et al.  Dhea Replacement in Women with Adrenal Insufficiency—Pharmacokinetics, Bioconversion and Clinical Effects on Well-Being, Sexuality and Cognition , 2000, Endocrine research.

[50]  Adele Cutler,et al.  Effects of dehydroepiandrosterone vs androstenedione supplementation in men. , 1999, Medicine and science in sports and exercise.

[51]  K. Barnhart,et al.  The effect of deydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life , 1999 .

[52]  M. Bidlingmaier,et al.  Dehydroepiandrosterone replacement in women with adrenal insufficiency. , 1999, The New England journal of medicine.

[53]  M. Flynn,et al.  Dehydroepiandrosterone replacement in aging humans. , 1999, The Journal of clinical endocrinology and metabolism.

[54]  T. M. Seligman,et al.  A pilot study employing Dehydroepiandrosterone (DHEA) in the treatment of chronic fatigue syndrome. , 1999, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[55]  M. Marberger,et al.  Dehydroepiandrosterone in the treatment of erectile dysfunction: a prospective, double-blind, randomized, placebo-controlled study. , 1999, Urology.

[56]  S. Yen,et al.  Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. , 1994, The Journal of clinical endocrinology and metabolism.

[57]  A. Morales.  Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age [published erratum appears in J Clin Endocrinol Metab 1995 Sep;80(9):2799] , 1994 .

[58]  J. Mulhall,et al.  Testosterone and Sexual Function , 2013 .

[59]  M. Mechling,et al.  Validation of the Female Sexual Function Index , 2006 .

[60]  Heloisa Junqueira Fleury,et al.  Aspectos diagnósticos e terapêuticos das disfunções sexuais femininas , 2006 .